The report reveals advancements in biotechnology, genome editing, and synthetic biology in agriculture, indicating rapid growth in the US agro-industrial complex.
The development of biotechnology in livestock farming, agriculture, healthcare, and a number of industrial sectors in the United States is a strategic priority for the next ten years. The implementation of artificial intelligence, the development of synthetic biology and genome editing in plants and animals, the cultivation of alternative proteins, and the creation of high-quality hybrid meat in bioreactors will lead to a transformation of traditional sectors of the agro-industrial complex. The growth of the US biotechnology market will be driven by a strong scientific base, venture capital, and a consistent national strategy, enshrined in regulatory and executive documents, clearly articulated to maintain leadership in the development of key technologies of the future.
No takes yet. Share an insight, caveat, or question.
Larisa Zhiganova (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: